Bladder cancer cell viability inhibition and apoptosis induction by baicalein through targeting the expression of anti-apoptotic genes

Abstract EN

The study was aimed to investigate the effect of baicalein, a flavonoid molecule isolated from the plant Oroxylum indicum on bladder cancer cell viability.

The results revealed that baicalein treatment of T24 and 253J bladder cancer cells targeted the expression of mRNA and proteins corresponding to the antiapoptotic genes.

RT-PCR assay showed that anti-apoptotic genes were markedly over-expressed in the bladder cancer cells.

Exposure of the bladder cancer cells to baicalein at 5 mg/mL doses for 72 h led to reduction in the expression of mRNA levels of antiapoptotic genes.

In T24 cells, the levels of BCL2, BclxL, XIAP and surviving was reduced by 65, 69, 58 and 72%, respectively.

In T24 and 253J cells exposure to baicalein for 72 h resulted respectively in 39 and 46% reduction in cell viability.

Baicalein treatment also induced apoptosis in the bladder cancer cells.

In T24 and 253J cells baicalein treatment at 5 mg/ mL for 72 h induced apoptosis in 79 and 86% cells respectively.

Thus, baicalein mediated reduction in antiapoptotic gene expression inhibits viability and induces apoptosis in bladder cancer cells.

Therefore, baicalein is of therapeutic importance for the development of bladder cancer treatment strategy.